Chrome Extension
WeChat Mini Program
Use on ChatGLM

A Basic ApoE-Based Peptide Mediator to Deliver Proteins Across the Blood-Brain Barrier: Long-Term Efficacy, Toxicity, and Mechanism

Molecular Therapy(2017)SCI 1区

Rutgers State Univ | Rutgers New Jersey Med Sch | Vet Affairs Puget Sound Hlth Care Syst | Univ Calif San Diego

Cited 22|Views23
Abstract
We have investigated delivery of protein therapeutics from the bloodstream into the brain using a mouse model of late-infantile neuronal ceroid lipofuscinosis (LINCL), a lysosomal disease due to deficiencies in tripeptidyl peptidase 1 (TPP1). Supraphysiological levels of TPP1 are delivered to the mouse brain by acute intravenous injection when co-administered with K16ApoE, a peptide that in trans mediates passage across the blood-brain barrier (BBB). Chronic treatment of LINCL mice with TPP1 and K16ApoE extended the lifespan from 126 to > 294 days, diminished pathology, and slowed locomotor dysfunction. K16ApoE enhanced uptake of a fixable biotin tracer by brain endothelial cells in a dose-dependent manner, suggesting that its mechanism involves stimulation of endocytosis. Pharmacokinetic experiments indicated that K16ApoE functions without disrupting the BBB, with minimal effects on overall clearance or uptake by the liver and kidney. K16ApoE has a narrow therapeutic index, with toxicity manifested as lethargy and/or death in mice. To address this, we evaluated variant peptides but found that efficacy and toxicity are associated, suggesting that desired and adverse effects are mechanistically related. Toxicity currently precludes direct clinical application of peptide-mediated delivery in its present form but it remains a useful approach to proof-of-principle studies for biologic therapies to the brain in animal models.
More
Translated text
Key words
tripeptidyl peptidase 1,blood brain barrier,intravenous,enzyme replacement therapy
PDF
Bibtex
AI Read Science
AI Summary
AI Summary is the key point extracted automatically understanding the full text of the paper, including the background, methods, results, conclusions, icons and other key content, so that you can get the outline of the paper at a glance.
Example
Background
Key content
Introduction
Methods
Results
Related work
Fund
Key content
  • Pretraining has recently greatly promoted the development of natural language processing (NLP)
  • We show that M6 outperforms the baselines in multimodal downstream tasks, and the large M6 with 10 parameters can reach a better performance
  • We propose a method called M6 that is able to process information of multiple modalities and perform both single-modal and cross-modal understanding and generation
  • The model is scaled to large model with 10 billion parameters with sophisticated deployment, and the 10 -parameter M6-large is the largest pretrained model in Chinese
  • Experimental results show that our proposed M6 outperforms the baseline in a number of downstream tasks concerning both single modality and multiple modalities We will continue the pretraining of extremely large models by increasing data to explore the limit of its performance
Try using models to generate summary,it takes about 60s
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Related Papers

The Inhibition of Acetylcholinesterase by a Brain-Targeting Polylysine-Apoe Peptide: Biochemical and Structural Characterizations.

2018 40th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) 2018

被引用1

The Role of Amyloid Oligomers in Neurodegenerative Pathologies

International Journal of Biological Macromolecules 2021

被引用29

The Blood–Brain Barrier and CNS Drug Delivery

Burger's Medicinal Chemistry and Drug Discovery 2021

被引用3

Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn
Chat Paper

要点】:本研究探究了一种基于ApoE的肽介导剂K16ApoE,用于将蛋白质治疗剂通过血脑屏障递送到大脑,实现了长期疗效,并分析了其毒性和作用机制。

方法】:研究者采用了一种小鼠模型LINCL,通过急性静脉注射与K16ApoE共给药的方式,将TPP1蛋白递送到小鼠脑内。

实验】:在LINCL小鼠模型中,通过长期给予TPP1和K16ApoE,将小鼠的平均寿命从126天延长至294天以上,减少了病理变化,并减缓了运动功能障碍。实验使用了生物素标记的示踪剂,并通过药代动力学实验评估了K16ApoE的效用,没有破坏血脑屏障,对肝脏和肾脏的影响也最小。研究中还评估了K16ApoE的变体肽,但发现疗效与毒性相关。